These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31271680)

  • 1. Using wearable monitors to assess daily walking limitations induced by ischemic pain in peripheral artery disease.
    Chaudru S; Jehannin P; de Müllenheim PY; Klein H; Jaquinandi V; Mahé G; Le Faucheur A
    Scand J Med Sci Sports; 2019 Nov; 29(11):1813-1826. PubMed ID: 31271680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sildenafil on maximum walking time in patients with arterial claudication: The ARTERIOFIL study.
    Omarjee L; Le Pabic E; Custaud MA; Fontaine C; Locher C; Renault A; Jaquinandi V; Azzola V; Barbeau-Terrier C; Laporte I; Ripoche M; Onillon Y; Chretien JM; Daniel V; Chao de la Barca JM; Homedan C; Reynier P; Abraham P; Mahé G
    Vascul Pharmacol; 2019; 118-119():106563. PubMed ID: 31152977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The improvement of walking abilities and endothelial function after the supervised training treadmill program (STTP) in patients with peripheral artery disease (PAD) is not related to prostacyclin and thromboxane release.
    Januszek R; Mika P; Nowobilski R; Maga P; Niżankowski R
    Int J Cardiol; 2016 Nov; 222():813-818. PubMed ID: 27522380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of transcutaneous electrical nerve stimulation on the improvement of walking distance in patients with peripheral arterial disease with intermittent claudication: study protocol for a randomised controlled trial: the TENS-PAD study.
    Besnier F; Sénard JM; Grémeaux V; Riédel M; Garrigues D; Guiraud T; Labrunée M
    Trials; 2017 Aug; 18(1):373. PubMed ID: 28797281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The addition of evolocumab to maximal tolerated statin therapy improves walking performance in patients with peripheral arterial disease and intermittent claudication (Evol-PAD study).
    Clavijo LC; Caro J; Choi J; Caro JA; Tun H; Rowe V; Kumar SR; Shavelle DM; Matthews RV
    Cardiovasc Revasc Med; 2023 Oct; 55():1-5. PubMed ID: 37142533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of structured home-based exercise on walking ability in patients with peripheral arterial disease: a meta-analysis.
    Li Y; Li Z; Chang G; Wang M; Wu R; Wang S; Yao C
    Ann Vasc Surg; 2015 Apr; 29(3):597-606. PubMed ID: 25449991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pain-free treadmill training on fibrinogen, haematocrit, and lipid profile in patients with claudication.
    Mika P; Wilk B; Mika A; Marchewka A; Nizankowski R
    Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):754-60. PubMed ID: 21450630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treadmill Measured vs. Questionnaire Estimated Changes in Walking Ability in Patients With Peripheral Artery Disease.
    Henni S; Ammi M; Semporé Y; Hersant J; Zegar G; Gourdier AS; Picquet J; Abraham P
    Eur J Vasc Endovasc Surg; 2019 May; 57(5):676-684. PubMed ID: 30982731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical training and antiplatelet treatment in stage II peripheral arterial occlusive disease: alone or combined?
    Mannarino E; Pasqualini L; Innocente S; Scricciolo V; Rignanese A; Ciuffetti G
    Angiology; 1991 Jul; 42(7):513-21. PubMed ID: 1863010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Walking economy before and after the onset of claudication pain in patients with peripheral arterial disease.
    Gardner AW; Ritti-Dias RM; Stoner JA; Montgomery PS; Scott KJ; Blevins SM
    J Vasc Surg; 2010 Mar; 51(3):628-33. PubMed ID: 20206808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise performance in patients with peripheral arterial disease who have different types of exertional leg pain.
    Gardner AW; Montgomery PS; Afaq A
    J Vasc Surg; 2007 Jul; 46(1):79-86. PubMed ID: 17540534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pain trajectory during treadmill testing in peripheral artery disease.
    Treat-Jacobson D; Henly SJ; Bronas UG; Leon AS; Henly GA
    Nurs Res; 2011; 60(3 Suppl):S38-49. PubMed ID: 21543960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 12-week supervised treadmill training on spatio-temporal gait parameters in patients with claudication.
    Konik A; Kuklewicz S; Rosłoniec E; Zając M; Spannbauer A; Nowobilski R; Mika P
    Disabil Rehabil; 2016; 38(12):1157-62. PubMed ID: 26314413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary evidence that low ankle-brachial index is associated with reduced bilateral hip extensor strength and functional mobility in peripheral arterial disease.
    Parmenter BJ; Raymond J; Dinnen PJ; Lusby RJ; Fiatarone Singh MA
    J Vasc Surg; 2013 Apr; 57(4):963-973.e1. PubMed ID: 23246081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red blood cell deformability in patients with claudication after pain-free treadmill training.
    Mika P; Spodaryk K; Cencora A; Mika A
    Clin J Sport Med; 2006 Jul; 16(4):335-40. PubMed ID: 16858218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability and short-term determinants of walking capacity in patients with intermittent claudication.
    Le Faucheur A; Noury-Desvaux B; Mahé G; Sauvaget T; Saumet JL; Leftheriotis G; Abraham P
    J Vasc Surg; 2010 Apr; 51(4):886-92. PubMed ID: 20347684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a Home-Based Exercise Intervention of Wearable Technology and Telephone Coaching on Walking Performance in Peripheral Artery Disease: The HONOR Randomized Clinical Trial.
    McDermott MM; Spring B; Berger JS; Treat-Jacobson D; Conte MS; Creager MA; Criqui MH; Ferrucci L; Gornik HL; Guralnik JM; Hahn EA; Henke P; Kibbe MR; Kohlman-Trighoff D; Li L; Lloyd-Jones D; McCarthy W; Polonsky TS; Skelly C; Tian L; Zhao L; Zhang D; Rejeski WJ
    JAMA; 2018 Apr; 319(16):1665-1676. PubMed ID: 29710165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External validation of the "walking estimated limitation calculated by history" (WELCH) questionnaire in patients with claudication.
    Abraham P; Godet R; Harbonnier M; Laneelle D; Leftheriotis G; Ouedraogo N
    Eur J Vasc Endovasc Surg; 2014 Mar; 47(3):319-25. PubMed ID: 24445082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of walking distances estimated by the patient, on the corridor and on a treadmill, and the Walking Impairment Questionnaire in intermittent claudication.
    Frans FA; Zagers MB; Jens S; Bipat S; Reekers JA; Koelemay MJ
    J Vasc Surg; 2013 Mar; 57(3):720-727.e1. PubMed ID: 23313183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between temporal-spatial gait parameters, gait kinematics, walking performance, exercise capacity, and physical activity level in peripheral arterial disease.
    Crowther RG; Spinks WL; Leicht AS; Quigley F; Golledge J
    J Vasc Surg; 2007 Jun; 45(6):1172-8. PubMed ID: 17543681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.